UPDATED Mar 27, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MVW | kr9.06 | 0.7% | 10.6% | kr264.6m | kr12.20 | PS24x | E66.0% | n/a | Materials | ||
GIG | kr34.00 | 4.6% | 44.1% | kr4.4b | kr49.20 | PE28.1x | E39.9% | n/a | Consumer Services | ||
FWRY | ج.م8.05 | 5.4% | 48.0% | ج.م28.6b | ج.م6.76 | PE44.4x | E36.7% | n/a | Diversified Financials | ||
ELABS | kr15.32 | 4.4% | 10.5% | kr1.6b | kr25.00 | PS23.5x | E124.6% | n/a | Software | ||
NOHAL | kr22.80 | 1.8% | -8.8% | kr891.6m | kr32.50 | PS8.7x | E56.0% | n/a | Food, Beverage & Tobacco | ||
RDUE | €8.42 | 1.0% | -19.0% | €52.6m | €11.70 | n/a | E42.0% | n/a | Capital Goods | ||
NVG | zł2.64 | 9.5% | 100.8% | zł92.4m | zł3.71 | PE9.5x | E28.5% | n/a | Diversified Financials | ||
SO | лв20.40 | -2.9% | n/a | лв210.3m | лв21.25 | PE18.9x | E23.9% | 0% | Food, Beverage & Tobacco | ||
WAYS | kr20.90 | 5.6% | -67.5% | kr168.7m | kr39.75 | PS1.5x | E81.8% | 0% | Tech | ||
KEBNI B | kr1.44 | 5.7% | 19.7% | kr389.4m | kr1.80 | PS5.4x | E96.2% | n/a | Tech | ||
AGP | €7.98 | -0.5% | 172.4% | €138.2m | €12.05 | n/a | E26.0% | n/a | Capital Goods | ||
CALTX | kr114.80 | 4.1% | -6.4% | kr6.2b | kr208.00 | PS5.1x | E47.6% | n/a | Pharmaceuticals & Biotech | ||
GWIND | ₺25.06 | 0.08% | 46.3% | ₺13.5b | ₺39.79 | PE21.7x | E60.9% | 1.8% | Utilities | ||
OSE | €4.87 | 6.1% | -3.4% | €105.0m | €7.15 | PS29.1x | E81.1% | n/a | Pharmaceuticals & Biotech | ||
FDE | €34.70 | -0.1% | -6.2% | €181.5m | €64.07 | PE23.1x | E32.3% | n/a | Energy | ||
MBTN | CHF0.032 | 105.8% | -94.6% | CHF113.6m | n/a | PB0.6x | E102.6% | n/a | Semiconductors | ||
ALNY | US$154.39 | 4.3% | -21.2% | US$19.4b | US$220.76 | PS10.6x | E60.8% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$22.49 | 0.7% | 34.0% | US$2.2b | US$25.20 | PE21.3x | E60.3% | 3.7% | Energy | ||
ELF | US$196.25 | -2.1% | 144.0% | US$10.9b | US$208.21 | PE84.2x | E30.8% | n/a | Household | ||
RCEL | US$16.50 | 2.2% | 21.5% | US$425.1m | US$26.49 | PS8.5x | E64.0% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$5.94 | -1.7% | 6.6% | US$246.4m | US$18.25 | PS14.9x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$15.57 | 1.3% | 4.8% | US$2.3b | US$29.75 | PE177.9x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.47 | 29.6% | 62.5% | US$233.3m | US$8.50 | PS2.8x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$16.83 | 8.4% | 156.2% | CA$577.7m | CA$23.32 | PE15.3x | E33.6% | 2.8% | Diversified Financials |